Speaker:

Anjuli Brighton, MBBCh, BAO  Chief Medical Resident, Internal Medicine, Mayo Clinic, Phoenix, Arizona.

The Pros and Cons of Procalcitonin: A Characterization of Elevated Procalcitonin in Hospitalized Patients

Objectives: 

• Review the existing literature on procalcitonin
• Introduce a retrospective study focusing on procalcitonin testing in inpatients at our institution
• Discuss the role of procalcitonin in informing clinical decisions

Speaker:

Molly Disbrow, MD  Chief Medical Resident, Internal Medicine, Mayo Clinic, Phoenix, Arizona.

Fecal Microbiota Transplation at Mayo Clinic Arizona: Outcomes and Satisfaction

Objectives:

• Discuss the scientific basis of fecal microbiota transplantation (FMT)
• Define patient selection criteria for FMT
• Describe the results of the Mayo Clinic Arizona FMT program

Locations:    

• Mayo Clinic Building, Taylor Auditorium
• Mayo Clinic Hospital, MCH Waugh Auditorium Side A (MCH 1-220A)
• Mayo Clinic Women’s Health Internal Medicine
• Mayo Clinic Family Medicine – Arrowhead
• Kingman Regional Medical Center
• Yuma Regional Medical Center
• Canyon Ranch Medical Center
• Mayo Clinic Primary Care – San Tan

ALL PHYSICIANS AND ALLIED STAFF ARE WELCOME

**NEW** ATTENDANCE REQUIREMENT 
A unique presentation code must be sent via text to 507-200-3010 
to record attendance and to ensure you receive CME credit for your attendance.  
NOTE:  Attendees must be present to receive code.

FACULTY DISCLOSURE

As a provider accredited by Accreditation Council on Continuing Medical Education (ACCME), Mayo Clinic College of Medicine, must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships is included course materials so participants may formulate their own judgments regarding the presentation.